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Introduction
More than two billion people are infected with tuberculosis (TB), and in 2006, 1.7 million people died from TB, including 231,000 people coinfected with HIV [1] . Extrapulmonary tuberculosis (EPTB) is increasing and accounts for one in five registered TB patients [2] . The commonest forms are lymph node, pleural, disseminated, pericardial and meningeal TB.
Abdominal (ATB) or intestinal tuberculosis (ITB) is the sixth most prevalent presentation of EPTB. The symptoms of ITB mimic those of many other conditions, especially inflammatory bowel diseases, such as Crohn's Disease. These are increasing in incidence in TB-endemic countries such as India and southeast Asia [3**,4] . Most patients are managed without laboratory confirmation, so simplified standardized guidelines are required based primarily on clinical observations. Standardized diagnostic algorithms are available for the more common forms of EPTB [2] but not for ITB.
Epidemiology
Poverty, malnutrition, overcrowding and HIV co-infection aid the spread of TB. In HIV coinfected patients, there is more EPTB and more rapid progression, due to a deficient host cellular immune response. The incidence and severity of ATB is increased in HIV-positive patients, by reactivation of latent TB and new infections [5*,6] .
The profile of patients with ATB differs around the globe. In Pakistan, ATB is the most common extrapulmonary site, and is increasing [7*] . Studies from Pakistan [7*,8,9 *] West Africa [10, 11] and Turkey [12*] found ATB to be a disease of young adults, especially women. A Zambian study [ However, studies from China [14] , Singapore [15*], India [16] and the UK [17*] found a lower incidence but equal or greater numbers of male patients. The UK is a low incidence country, but the proportion of EPTB is rising and varies according to place of birth: 29% of UK-born cases had EPTB but 51% of non-UK born cases [18] . Ramesh et al [17*] found that 91% of UK patients with ATB were of South Asian origin. In addition to the effect of age, sex and immune status, the host-pathogen interaction may differ between ethnic groups due to host susceptibility/resistance factors [19**] .
Pathogenesis
The principal cause of ITB is Mycobacterium tuberculosis . ITB may be a primary infection, or secondary following reactivation, usually from a primary pulmonary focus. Assumed routes of infection of the gastrointestinal tract are ingestion, for example, of bacilli in sputum from an active focus in the lung, haematogenous spread from the lung, from infected lymph nodes and direct spread from adjacent organs. Unpasteurized milk and milk products are regarded as the main route of transmission of zoonotic TB caused by Mycobacterium bovis in countries where there are no effective eradication programmes. However, in the UK, M. bovis accounts only for 0.5 -1.5% of all culture-confirmed TB cases [20] . A rare case of ITB in a 90-day infant was due to postnatal transmission from the mother [21] .
The genotype of M. tuberculosis has important clinical consequences, as it influences the presenting features of pulmonary and EPTB. The East Asian/Beijing lineage, predominantly found in Asia, is associated with greater dissemination and a higher incidence of drug- M-cells, found in the follicle-associated epithelium of intestinal Peyer's patches of gutassociated lymphoid tissue, provide a route of entry for pathogens into the mucosa and can phagocytose tubercle bacilli. Therefore, the higher number of lymphoid Peyer's patches in young adults may be one reason why ITB is often associated with this age group.
Pathology
The ileocaecal region is the most common site of involvement, although ATB can have a focus at any site in the gastrointestinal tract, associated lymph nodes and/or the peritoneum.
ITB usually has one of three forms: ulcerative, hypertrophic or ulcerohypertrophic or fibrous [24] . Tuberculous granulomas initially form in the mucosa or Peyer's patches, whilst ulcers are relatively superficial, with a different appearance from those in Crohn's disease. ITB progresses slowly and presents late with complications, especially acute or sub-acute obstruction due to mass (tuberculoma), stricture formation in the ileocaecal region or perforation leading to peritonitis. Peritoneal TB (PTB) is rare in the absence of any other debilitating disease. In PTB the peritoneum is studded with multiple yellow-white tubercles.
Site of involvement and clinical presentation
ATB is difficult to diagnose because of its lack of specific symptoms and variable In ITB, all regions from the oesophagus to the rectum may be involved. Oesophageal TB is very uncommon and mimics oesophageal carcinoma. Gastroduodenal TB may mimic peptic ulcer disease or present with symptoms of pyloric obstruction, thus being confused with adenocarcinoma. Ileocaecal TB presents with abdominal pain, a right iliac fossa mass and/or altered bowel habits and bleeding, which mimics Crohn's disease, carcinoma, amoebiasis, enteric fever or Yersinia enterocolitica. Colonic TB occurs in about 10% of cases, mimicking carcinoma or, more rarely, ulcerative colitis. In rectal TB the predominant symptom is bleeding, and in anal TB, fistulae are common, both mimicking carcinoma or Crohn's disease. The main presenting symptoms are shown in Table 1 In children the presenting features of PTB are similar with abdominal pain, fevers and ascites [30*,31] . Malnutrition is a common feature of ATB in children. calcified, low-density lesions [33] . Some authors believe CT to be the imaging method of choice for ATB, but on balance, MRI is preferable to CT because of the lack of radiation, particularly for chronic conditions where repeated images may be necessary and in children.
MRI scans give a variable appearance of lymphadenopathy depending on the weighting and the stage of the granuloma. Typically, there is a hyperdense centre and hypodense rim in caseating granuloma (T2-weighted). Abnormal bowel wall shows a decreased intensity on T1-weighting and an increased density on T2-weighting. Fine needle aspirates (FNAs) are less invasive, so are more feasible in resource-poor settings.
FNAs, combined with a Ziehl-Neelsen stain and PCR, ensured a speedy and reliable diagnosis in HIV-positive children in South Africa [46] . In this study, TB was the second commonest diagnosis in children who presented with mass lesions. Similarly, an Indian study [47] found that from 1999-2006, 92 cases of ATB were diagnosed by FNA cytology, and it was a simple, fast, accurate and inexpensive diagnostic procedure.
Laboratory investigations
Microscopy is the most rapid diagnostic tool. In ideal settings it can produce same day (CA-125), may be raised in PTB, so this possibility should be considered, especially in patients from TB-endemic countries [51] . In female patients with ascites, abdominal pain and elevated CA-125 levels, PTB mimics malignancies such as ovarian cancer.
Serological tests for EPTB are inconsistent and perform no better than microscopy. However, In-house PCRs have been described but are not readily transferred to other centres and will presumptive antituberculous treatment to be maintained or discontinued [58] .
A PCR method based on IS1081 [59] has more potential as there are 6 copies/cell of IS1081 in all members of the M. tuberculosis complex. PCR inhibition, a common problem when clinical samples are used directly, must be controlled, and PCRs should be optimized to maximum efficiency of reaction. This is best carried out using newer methodologies, including real-time PCR, which may not be economically feasible in resource-poor countries.
Management and treatment
Surgical management is conservative, with perforation being managed by resection and endend anastomosis and obstruction managed by strictureplasty, or in severe cases by resection.
Obstruction and fistulae may respond to purely medical management. Because of the difficult diagnostic challenge of ATB, a high index of suspicion is needed, particularly in nonendemic areas, as medical treatment can be curative and save unnecessary surgery [60*].
Standard treatment for ITB is conventional chemotherapy (Rifampicin+Isoniazid+Pyrazinamide+Ethambutol, RIPE) for 2 months, with Rifampicin+Isoniazid (RI) continuing for a further 4 -7 months. Most countries adopt the WHO guidelines of directly observed treatment short course (DOTS) given on a daily or 13 thrice weekly basis. A study [61] comparing daily RIPE for 2 months followed by RI for 7 months, with DOTS receiving RIPE thrice weekly for 2 months followed by RI thrice weekly for 4 months, showed comparable cure rates .
The role of corticosteroids in ITB is not clear, and further studies are required. Management of patients who are co-infected with TBand HIV presents problems related to compliance, drug interactions and immune reconstitution inflammatory syndrome [62] . Avoidance of drug interactions can be improved if rifampicin is replaced by rifabutin [62] , or nucleos(t)ide- Patients who receive antitumour necrosis factor (antiTNF) therapy for Crohn's disease are susceptible to TB reactivation or acquisition [65, 66] . To reduce latent TB reactivation patients should receive RI for 3 months prior to commencement of anti-TNF therapy, or if they develop TB during treatment, be given standard anti-tuberculous therapy.
Future developments will be in novel drug delivery systems such as the slow release of antituberculous drugs from polyDL-lactide-coglycolide (PGL) and gelatin, although their effects on clinical cure rates are not yet reported [67] . Other developments for the treatment of ITB could involve the use of targeted gold nanoparticles to block uptake of iron to the 14 microbe or targeted gold/iron nanoparticles combined with radiofrequence-induced heating, which could kill the microbe. Both techniques are independent of microbial antibiotic sensitivity and would be active against multi-drug resistant TB.
Conclusions
ITB has been somewhat neglected by researchers, although it is increasing due to
HIVcoinfection. It is a particular problem in some localities, possibly due to the genetic characteristics of host and pathogen, plus socioeconomic factors. In resource-poor countries diagnosis will continue to be mainly by clinical presentation, so a high index of suspicion is required. Several sophisticated imaging and detection techniques are available, but molecular methods require validation for ITB. Innovative work is in progress formulating oral drug delivery systems.
